Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |